JUN 04, 2020 2:00 PM EDT

Lipoma Preferred Partner (LPP) Regulates Breast Cancer Cell Migration and Invasion

Speaker
  • Associate Professor & Director, Advanced BioImaging Facility, McGill University, Montreal
    Biography
      I have been working in the field of quantitative bioimaging for over 25 years. My research has focused on applying biophysical techniques to fluorescence microscopy images to extract quantitative data measuring protein distributions, dynamics and interactions. I have applied these techniques to study proteins that regulate cell adhesion and migration to understand how migration is regulated at the molecular level in normal and diseased cellular systems. My research has also focused on optimizing live cell imaging to minimize phototoxicity and ensure the collection of high-fidelity data that is free of light induced artifacts. Quality control and standards for quantitative light microscopy have also been an important area of research. For 15 years, I have been directing the Advanced BioImaging Facility (ABIF) and developing and implementing active learning courses and workshops in fundamental and advanced light microscopy. In 2016, I also took over management of the Cell Imaging and Analysis Network (CIAN) light and the Cystic Fibrosis Translation Research Centre (CFTRc) light microscopes. Overall, I manage 18 research microscopes and a team of staff who provide high quality training and support for these advanced technologies.

    Abstract

    In 2019, over 220,000 Canadians will be diagnosed with cancer and 82,000 will die of the disease. Approximately 90% of cancer related deaths are the result of metastatic disease. This is indeed the case for breast cancer where metastasis is the deadliest aspect of disease progression. We have implicated the Lipoma Preferred Partner (LPP) protein as an important mechanosensitive integrator of TGFβ-mediated breast cancer cell migration and invasion, two cellular processes that are critical for cancer metastasis. Two important structures that regulate migration and invasion are cellular adhesions (migration) and invadopodia (invasion). Cell-matrix adhesions are dynamic structures that link the extracellular matrix to the internal cytoskeleton. Adhesions are tightly regulated in space and time to control cell migration. In turn, invadopodia are structures that form enabling cells in exit primary tumors, enter the blood stream and enter distant tissues at sites of metastasis. Our work shows that LPP is an important regulator of cell-matrix adhesion and invadopodia formation and substrate degradation in response to TGFβ stimulation. We demonstrate this in several cell breast cancer cell lines including triple negative 4T1 cells. Using biophysical tools and quantitative imaging we link LPP to regulation of cell migration through regulation of adhesion dynamics, mechanosensing, regulation of tension at individual adhesions and invasion on substrates with variable biomechanical properties.


    Show Resources
    You May Also Like
    APR 07, 2020 8:00 AM PDT
    C.E. CREDITS
    APR 07, 2020 8:00 AM PDT
    DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
    JUN 17, 2020 1:30 PM PDT
    C.E. CREDITS
    JUN 17, 2020 1:30 PM PDT
    Understanding the complex interplay between a pathogen and the host response is important to developing effective vaccines and therapeutics. The nCounter® Analysis System and GeoMx®...
    FEB 26, 2020 9:00 AM PST
    C.E. CREDITS
    FEB 26, 2020 9:00 AM PST
    DATE: February 26, 2020 TIME: 9:00am PST 3D cell culture and analysis and the study of organoids and spheroids are becoming more prevalent as a research method in publications as traditional...
    FEB 19, 2020 11:00 AM PST
    C.E. CREDITS
    FEB 19, 2020 11:00 AM PST
    DATE: February 19, 2020TIME: 11:00am PST, 2:00pm EST...
    JUN 23, 2020 10:00 AM PDT
    C.E. CREDITS
    JUN 23, 2020 10:00 AM PDT
    DATE: June 23, 2020 TIME: 10:00am PT Human mesenchymal stromal or stem cells (MSCs)-based immunomodulation treatment has been proposed as a suitable therapeutic approach for many diseases, s...
    MAY 08, 2020 10:00 AM PDT
    C.E. CREDITS
    MAY 08, 2020 10:00 AM PDT
    DATE: May 8, 2020 TIME: 10:00am PT, 11:00am MT, 1:00pm ET The application of next generation sequencing to interrogate immune repertoires and methods in which these highly complex dataset...
    Loading Comments...
    Show Resources